At a glance
ClinicalIndex Comparison RecordN/ACompleted· 584 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts
In Brief
An observational study for Coronary Artery Disease. Completed, enrolled 584 participants across 15 sites in 8 countries.
Detailed Summary
The objective of the PLATFORM Study is to compare clinical outcomes, resource utilization, and quality of life (QOL) of FFRCT-guided evaluation versus standard practice evaluation in patients with suspected CAD in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in the diagnosis of CAD
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesAustria, Belgium, Denmark, France, Germany, Italy, United Kingdom, United States
CollaboratorsDuke Clinical Research Institute
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedSep 2013
Primary CompletionDec 2015
TodayJul 2026
First PostedSep 17, 2013
Enrollment StartSep 1, 2013
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.8 years ago